Related Experiment Video

Updated: Aug 22, 2026

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

Endothelial therapy of atherosclerosis and its risk factors

Tobias Traupe1, Jana Ortmann, Klaus Münter

  • 1Medical Policlinic, Department of Medicine, University Hospital Zürich, Switzerland.

Current Vascular Pharmacology
|August 24, 2004
PubMed

Insights

Atherosclerosis impairs vascular endothelial cell function, reducing nitric oxide bioavailability. Therapies targeting these pathways, like statins, improve vascular function and reduce cardiovascular complications in patients with atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Pharmacology

Background:

  • Atherosclerosis is a chronic inflammatory vascular disease causing significant cardiovascular morbidity and mortality globally.
  • Endothelial dysfunction, characterized by reduced nitric oxide (NO) bioavailability and increased oxidative stress, is central to atherosclerosis progression.
  • This dysfunction contributes to vasoconstriction, inflammation, thrombosis, and cell proliferation within blood vessels.

Purpose of the Study:

  • To review the mechanisms underlying endothelial dysfunction in atherosclerosis.
  • To explore therapeutic strategies aimed at restoring endothelial function and improving outcomes in atherosclerosis patients.

Main Methods:

  • Review of existing literature on atherosclerosis pathophysiology and endothelial function.
  • Analysis of pharmacological interventions targeting endothelial pathways, including renin-angiotensin system inhibition, statin therapy, and endothelin receptor blockade.

Main Results:

  • Impaired endothelial function in atherosclerosis is linked to reduced NO and increased free radicals.
  • Therapeutic strategies such as renin-angiotensin system inhibition, statins, and endothelin receptor blockers can restore NO bioactivity.
  • These interventions demonstrate efficacy in experimental models and clinical settings for atherosclerosis.

Conclusions:

  • Restoring endothelial NO bioactivity is a key therapeutic goal in managing atherosclerosis.
  • Pharmacological approaches targeting endothelial pathways offer significant benefits for patients at risk or with established atherosclerosis.
  • Improving endothelial function can mitigate vascular and myocardial complications associated with this disease.

More Related Videos

On-Chip Endothelial Inflammatory Phenotyping12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...